Form 4 for GILD Gilead Sciences
Accepted 2026-04-29 17:53:42 ET · period of report 2026-04-28 · accession 0001638643-26-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-04-29 17:53 | 2026-04-28 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $129.16 | -10.0K | 632.6K | -2% | -$1.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-28 | S | D | 6,950 | $128.79 | 635,617 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. (F2) Sale prices for the transactions reported range from $128.41 to $129.325. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 2 | Common | Common Stock | 2026-04-28 | S | D | 3,050 | $130.01 | 632,567 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. (F3) Sale prices for the transactions reported range from $129.42 to $130.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |